In October, the FDA’s Obstetrics, Reproductive and Urologic Drugs Advisory Committee voted that Makena should not remain on the market after a large study failed to show that it was effective
“While we stand by Makena’s favorable risk-benefit profile, including its efficacy in women at highest risk of preterm birth, we are seeking to voluntarily withdraw the product and work with the FDA to effectuate an orderly wind-down,” Covis Chief Innovation Officer Dr. Raghav Chari said in a news release. . It also voted that a postmarket trial didn’t show any benefit to babies and that the evidence didn’t show that Makena reduced the risk of preterm birth in women who had had one before.
Covis says that soon after the committee hearing, it outlined a plan for withdrawal that included a wind-down period allowing patients to finish the 21-week course of treatment. However, the FDA’s Center for Drug Evaluation and Research rejected the plan. “Covis remains prepared to work cooperatively with the Agency to accomplish an orderly wind-down and withdrawal of Makena and its generics from the market,” the company said Monday in a letter to FDA Commissioner Dr.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US senators call for UN probe into secret Iranian torture centers exposed by CNN | CNNA committee of US senators has called on the United Nations to investigate a network of secret torture centers in Iran exposed by a CNN investigation last month.
Read more »
Oklahoma voters will reject legalization of recreational marijuana, CNN projects | CNN PoliticsVoters in Oklahoma will reject a ballot measure that would have legalized recreational marijuana in the state for adults ages 21 and older, CNN projects.
Read more »
Drug to Prevent Preterm Births to Be Pulled From MarketThe maker of Makena said it will stop selling the drug to prevent preterm births after a study couldn’t confirm the medicine worked
Read more »
Buffett-backed EV maker BYD erases $18bn in value amid Tesla price warWarren Buffett-backed Chinese EV maker BYD has seen $18 billion in value wiped out amid Tesla's price war
Read more »
Chinese EV maker announces satellite constellation to support new carsGeely is promising centimeter-level positioning accuracy with its own satellite constellation to be launched by 2025. This is expected to support driving features.
Read more »